2. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54:1-31.
4. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut 1996;38 Suppl 2:S5-S12.
5. Awole M, Gebre-Selassie S. Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. Ethiop J Health Dev 2005;19:45-50.
6. Walle F, Asrat D, Alem A, Tadesse E, Desta K. Prevalence of hepatitis B surface antigen among pregnant women attending antenatal care service at Debre-Tabor Hospital, Northwest Ethiopia. Ethiop J Health Sci 2008;17:13-20.
7. Ramos JM, Toro C, Reyes F, Amor A, Gutiérrez F. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. J Clin Virol 2011;51:83-85. PMID:
21330196
10. Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. N Am J Med Sci 2011;4:7-13.
11. Pennap GR, Osanga ET, Ubam A. Seroprevalence of hepatitis b surface antigen among pregnant women attending antenatal clinic in federal medical center Keffi, Nigeria. Res J Med Sci 2011;5:80-82.
12. Apuzzio J, Block JM, Cullison S, Cohen C, Leong SL, London WT, et al. Chronic hepatitis B in pregnancy: a workshop consensus statement on screening, evaluation, and management, Part 1. Female Patient 2012;37:22-27.
13. Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis 2010;14:e1024-e1031. PMID:
20870439
15. Binder A. Double antibody sandwich ELISA for the cut-off value determination of hepatitis B surface antigen (HBsAg) in human serum or plasma. Wiener Neudorf: Dialab GmbH; 2013. p 4-8.
16. MacLean B, Hess RF, Bonvillain E, Kamate J, Dao D, Cosimano A, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. S Afr Med J 2011;102:47-49. PMID:
22273139
18. Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, Mugo F, et al. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J 2006;83:485-493. PMID:
17447350
21. Candotti D, Danso K, Allain JP. Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol 2007;88:2686-2695. PMID:
17872520
22. Euler GL, Wooten KG, Baughman AL, Williams WW. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 2003;111:1192-1197. PMID:
12728137
23. Souza MT, Pinho TL, Santos MD, Santos AD, Monteiro VL, Fonsê-ca LM, et al. Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil. Braz J Infect Dis 2012;16:517-520. PMID:
23168305
24. Vázquez-Martínez JL, Coreño-Juárez MO, Montaño-Estrada LF, Attlan M, Gómez-Dantés H. Seroprevalence of hepatitis B in pregnant women in Mexico. Salud Publica Mex 2003;45:165-170. PMID:
12870417
26. El-Magrahe H, Furarah AR, El-Figih K, El-Urshfany S, Ghenghesh KS. Maternal and neonatal seroprevalence of hepatitis B surface antigen (HBsAg) in Tripoli, Libya. J Infect Dev Ctries 2010;4:168-170. PMID:
20351458
28. Alegbeleye JO, Nyengidiki TK, Ikimalo JI. Maternal and neonatal seroprevalence of hepatitis B surface antigen in a hospital based population in South-South, Nigeria. Int J Med Med Sci 2013;5:241-246.